PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation
Open Access
- 9 August 2012
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 3 (8) , e361
Abstract
Recent observations indicate prostatic diseases are comorbidities of systemic metabolic dysfunction. These discoveries revealed fundamental questions regarding the nature of prostate metabolism. We previously showed that prostate-specific ablation of PPARγ in mice resulted in tumorigenesis and active autophagy. Here, we demonstrate control of overlapping and distinct aspects of prostate epithelial metabolism by ectopic expression of individual PPARγ isoforms in PPARγ knockout prostate epithelial cells. Expression and activation of either PPARγ 1 or 2 reduced de novo lipogenesis and oxidative stress and mediated a switch from glucose to fatty acid oxidation through regulation of genes including Pdk4, Fabp4, Lpl, Acot1 and Cd36. Differential effects of PPARγ isoforms included decreased basal cell differentiation, Scd1 expression and triglyceride fatty acid desaturation and increased tumorigenicity by PPARγ1. In contrast, PPARγ2 expression significantly increased basal cell differentiation, Scd1 expression and AR expression and responsiveness. Finally, in confirmation of in vitro data, a PPARγ agonist versus high-fat diet (HFD) regimen in vivo confirmed that PPARγ agonization increased prostatic differentiation markers, whereas HFD downregulated PPARγ-regulated genes and decreased prostate differentiation. These data provide a rationale for pursuing a fundamental metabolic understanding of changes to glucose and fatty acid metabolism in benign and malignant prostatic diseases associated with systemic metabolic stress.Keywords
This publication has 44 references indexed in Scilit:
- PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasiaDifferentiation, 2011
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Metabolic alterations and targeted therapies in prostate cancerThe Journal of Pathology, 2010
- Pioglitazone attenuates prostatic enlargement in diet‐induced insulin‐resistant rats by altering lipid distribution and hyperinsulinaemiaBritish Journal of Pharmacology, 2010
- The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other CausesCancer Epidemiology, Biomarkers & Prevention, 2010
- Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanismsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitizationProceedings of the National Academy of Sciences, 2009
- Disruption of PPARγ signaling results in mouse prostatic intraepithelial neoplasia involving active autophagyCell Death & Differentiation, 2009
- Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese miceBiochemical and Biophysical Research Communications, 2009